为自闭症成人提供健康检查:一项整群随机对照试验的研究方案
本研究为自闭症成人初级保健健康检查的临床与成本效果整群随机对照试验,计划通过参与的全科诊所招募200名18岁及以上提供基线数据的自闭症成人,随机分为干预组与对照组。主要结局为9个月时从全科医生记录中采集的新发现并已满足的健康需求/疾病发生率,次要结局包括成本效果、健康监测与健康促进需求满足程度、社会照护需求、一般健康与生活质量变化及资源使用成本,并辅以定性研究探索可接受性。
要点
- 整群随机对照试验,比较初级保健健康检查与常规照护对自闭症成人的临床与成本效果。
- 主要结局为9个月时全科医生记录中新发现并已满足的健康需求/疾病发生率。
- 若干预有效,可为将健康检查纳入常规医疗提供强证据,以早期诊断和治疗并减少健康不平等。
核心结论
- 本研究将评估自闭症成人初级保健健康检查在识别新健康问题与需求方面的效果与成本效果。
- 作者认为若干预有效,将为纳入常规医疗提供强证据,从而 enabling 更早诊断与治疗机会并减少自闭症人群经历的健康不平等。
研究设计与样本
- 临床与成本效果整群随机对照试验,由卫生专业人员、自闭症人士、照护者与支持者及研究者共同设计并实施。
- 初级保健诊所被随机分为干预组或对照组,通过参与诊所招募200名18岁及以上提供基线数据的自闭症成人。
- 数据通过定量与定性方法收集,主要结局为9个月时从参与者全科医生记录中采集的新发现并已满足的健康需求/疾病发生率。
关键数值与推荐
- 主要结局:9个月时新发现并已满足的健康需求/疾病发生率,数据来自参与者全科医生记录。
- 次要结局包括:以9个月每获得一个质量调整生命年所需增量成本表示的成本效果;9个月时健康监测与健康促进需求满足程度;9个月时识别的社会照护需求发生率;参与者或照护者一般健康变化;生活质量变化;初级与次级卫生及社会照护资源使用与成本。
- 定性研究将探索对健康检查可接受性、实用性及未来使用的看法。
临床怎么用
- 原文未据此给出推荐。
局限性
- 试验注册为回顾性注册,于2023年7月20日完成(ISRCTN注册号:30156776)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autistic people commonly have physical and mental health conditions. They also frequently experience barriers to accessing healthcare, contributing to problems identifying and treating health conditions. These factors may lead to increased and earlier morbidity and lower average life expectancy for autistic people. Health checks specifically designed for autistic people, incorporating adjustments to healthcare, may help to overcome these barriers and reduce health inequalities. This trial aims to investigate the clinical and cost-effectiveness of a primary care health check for autistic adults and explore factors related to implementation such as acceptability and feasibility of delivery. The trial is co-designed and delivered by health professionals, autistic people, carers and supporters, and researchers. METHODS: This is a clinical and cost-effectiveness, cluster randomised controlled trial of a primary care health check for autistic adults. Primary care practices will be randomised into one of two groups (intervention or control). Two hundred autistic adults (aged 18 years and over) who provide baseline data will be recruited via participating practices. Data will be collected through quantitative and qualitative methods. The primary outcome will be the incidence of new health needs/conditions detected and met at 9 months (data gathered from participant's GP records). Secondary outcomes will include the following: cost-effectiveness, measured as incremental cost per quality-adjusted life year gained over 9 months; the extent of health monitoring and health promotion needs met at 9 months; the incidence of social care needs identified at 9 months; changes in participant or carer general health; changes in quality of life; primary and secondary health and social care resource usage and costs. A qualitative study will explore views about the acceptability of the health check, its utility and future use. DISCUSSION: This study will examine the effectiveness and cost-effectiveness of a primary care health check for autistic adults in identifying new health conditions and needs. If the intervention is effective, it would provide strong evidence for implementation into routine healthcare, therefore enabling earlier health condition diagnosis and opportunities for treatment, reducing the health inequalities experienced by autistic people. TRIAL REGISTRATION: ISRCTN, retrospectively registered on 20 July 2023. https://www.isrctn.com/ISRCTN30156776 (ISRCTN registration number: 30156776).
引用
- Parr JR, Taylor H, Wilson C, et al. Health checks for autistic adults: study protocol for a cluster randomised controlled trial. Trials. 2024. PMID: 39741343. doi:10.1186/s13063-024-08641-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。